Catalogo dei prodotti della ricerca

ROCCO, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.619
EU - Europa 762
AS - Asia 694
SA - Sud America 13
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 4.102
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.594
SG - Singapore 298
IN - India 297
IT - Italia 187
UA - Ucraina 176
FI - Finlandia 151
CN - Cina 86
SE - Svezia 77
GB - Regno Unito 39
DE - Germania 34
RU - Federazione Russa 31
IE - Irlanda 27
CA - Canada 21
BE - Belgio 12
AR - Argentina 9
FR - Francia 7
TG - Togo 5
MX - Messico 4
NL - Olanda 4
TW - Taiwan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
PL - Polonia 3
BG - Bulgaria 2
BR - Brasile 2
CH - Svizzera 2
ES - Italia 2
GR - Grecia 2
LT - Lituania 2
TN - Tunisia 2
TR - Turchia 2
AT - Austria 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EU - Europa 1
ID - Indonesia 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
RO - Romania 1
SC - Seychelles 1
Totale 4.102
Salva come PNG Salva come JPEG
Città #
Chandler 388
Princeton 263
Singapore 187
Fairfield 176
Plano 160
Boston 128
Ann Arbor 122
Ashburn 102
Wilmington 102
Des Moines 97
Woodbridge 95
Santa Clara 85
Beijing 62
Cambridge 61
Jacksonville 57
Houston 52
Seattle 46
Millbury 41
Andover 38
San Diego 28
Fremont 27
Dearborn 26
Dublin 26
Rome 23
Southend 23
Norwalk 19
Toronto 18
San Mateo 17
Moscow 16
Brussels 11
Mannheim 10
Bühl 9
Falkenstein 9
Federal 9
Milan 9
Boardman 8
Falls Church 5
Lomé 5
Guangzhou 4
Helsinki 4
Keelung 4
Laurel 4
Lawrence 4
Muizenberg 4
Provo 4
Trumbull 4
Bari 3
Bologna 3
Chicago 3
Dallas 3
Dubai 3
Hefei 3
London 3
Naples 3
New Orleans 3
San Paolo di Civitate 3
Shenyang 3
Baotou 2
Cagliari 2
Collegno 2
Conselve 2
Edinburgh 2
Florence 2
Hammamet 2
Istanbul 2
Kunming 2
Madrid 2
Mazara Del Vallo 2
Messina 2
Mexico City 2
Montalto Uffugo 2
Nanjing 2
New Delhi 2
Palermo 2
Porcari 2
Pune 2
Rimini 2
Romagnano Sesia 2
San Valentino Torio 2
Sandston 2
Sofia 2
Termoli 2
Vicenza 2
Zabrze 2
Altofonte 1
Anzio 1
Auburn Hills 1
Auckland 1
Barga 1
Bern 1
Betzdorf 1
Bishkek 1
Bisignano 1
Bremen 1
Brescia 1
Buffalo 1
Caserta 1
Civita Castellana 1
Clearwater 1
Cochabamba 1
Totale 2.695
Salva come PNG Salva come JPEG
Nome #
L'iperspermia come causa di sterilità: effetto del trattamento con metoclopramide 149
Terapia della sindrome dell’ovaio policistico con bromocriptina 86
Prolactin response to acute administration of different L-Dopa plus Decarboxylase inhibitors in Parkinson's disease 70
Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response 65
Inverse correlation between morning plasma cortisol Levels and MMPI psychasthenia and depression scale scores in victims of mobbing with adjustment disorders 62
Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome 57
Acute renal failure and acute respiratory distress syndrome in a patient with type 2 diabetes, pre-existing postive p-ANCA autoantibodies and moderately impaired renal function 56
Effect of long term administration of ovine prolactin on hypothalamic-pituitary testicular axis in rat 55
Role of serotonin in the control of prolactin secretion: effect of antiserotoninergic drugs in normal subjects and in hyperprolactinaemic states 55
Reproductive parameters in prolactinaemic men 52
Hyperprolactinaemia in polycystic ovary syndrome and in pituitary adenoma: prolactin response to pharmacological stimuli 51
Plasma prolactin response to neuroactive drugs after long term dopaminergic treatment in Parkinson's disease 49
La benserazide eleva i livelli circolanti di prolattina con meccanismo sovraipofisario 47
Influence of hyperprolactinaemia due to metoclopramide on gonadal function in men 45
Different hormonal patterns in patients with PRL secreting tumor and hyperprolactinaemic PCO syndrome 44
Phospholipid liposomes and prolactin secretion: effects on spontaneous and drug-induced hyperprolactinaemia 44
Androgeni e bulbo pilifero 42
Approccio psiconeuroendocrino nella sessualità maschile 41
Peptidergic control of prolactin release at the pituitary level: in vitro studies 39
Confronto tra la risposta della prolattina e dell'ormone della crescita a farmaci dopaminergici in pazienti parkinsoniani sotto trattamento cronico con L-Dopa 39
The effect of haloperidol decanoate on prolactin and clinical response in patients with chronic schizophrenia 38
Effetti della sauvagina, nuovo peptide estratto dalla pelle di anfibio, sulla secrezione di PRL, ACTH e beta-endorfina da parte di cellule ipofisarie di ratto in perfusione 38
Psychoneuroendocrine aspects of polycystic ovary syndrome 38
Potent in vivo and in vitro prolactin inhibiting activity of sauvagine, a frog skin peptide 37
Condition of dopaminergic receptor in idiopathic and drug-induced Parkinsonism 37
Prolactin release in the polycystic ovary syndrome 37
Inhibitory effect of dopaminergic drugs on luteinizing hormone secretion in hyperandrogenism 36
Polycystic ovary syndrome with hyperprolactinemia in adolescent girl: results of bromocriptine treatment 36
Hyperprolactinemia in polycystic ovary syndrome: diagnostic applications of neuroactive drugs 35
Calcified pituitary adenoma associated with severe hyperprolactinaemia 35
Association between human leukocyte antigen (HLA) and interferon- induced thyroid diseases in four patients with HCV-related chronic hepatitis. 35
Prolactin and idiopathic oligospermia 35
Diagnostica endocrina nelle donne infertili con iperprolattinemia 34
Azione della L-Dopa e dei diversi inibitori della decarbossilasi sulla prolattina nel Morbo di Parkinson 34
Comportamento della prolattinemia in corso di terapia elettroconvulsivante in pazienti psicotici 34
Behavior of plasma prolactin levels during chronic neuroleptic treatment in psycothic patients 33
Impotence and dopamine receptor blocking drugs 33
The hypothalamic-pituitary-thyroid axis in subjects with subclinical thyroid diseases: The impact of the negative feedback mechanism 33
Controllo ipotalamico della secrezione ipofisaria di prolattina e gonadotropine 32
Neuroendocrine investigations in Parkinson's disease 32
Chronic anovulation in polycistic ovary syndrome: role of hyperprolactinaemia and its suppression with bromocriptine 32
Pharnacological interaction between neuroleptics and brain cortex phospholipids on plasma prolactin levels 32
Prolactin levels and depot fluphenazine treatment in psychotic patients 31
Dopaminergic system and anterior pituitary hormones during early menopause 30
Emotional and hormonal responses to sexually arousing stimuli 29
Seminal fluid alterations due to metoclopramide induced hyperprolactinemia in man 29
Polycystic ovary syndrome and hyperprolactinaemia 29
Prolattina e Sessualità 29
Azione della L-Dopa e dei diversi inibitori della decarbossilasi sulla prolattina nel Parkinsonismo farmacologico 29
Sexual disfunction and prolactin levels 29
Risposta funzionale della prolattina e del turnover de metaboliti acidi liquorali agli agonisti recettoriali dopaminergici nelle sindromi parkinsoniane farmacologiche 28
High incidence of hyperprolactinaemia in polycystic ovary syndrome: functional or tumoral origin? 28
Use of metoclopramide to reduce ejaculate volume in hyperspermic and normospermic men 28
Brain dopamine and premature ejaculation: results of treatment with dopamine antagonists 28
Dopaminergic drugs and polycystic ovarian syndrome 28
Chronic neuroleptic treatment in schizophrenia: a supposed shift in the control of prolactin secretion 28
Comportamento della prolattina e della funzione testicolare in corso di trattamento cronico con farmaci neurolettici 28
Lack of effect of benserazide in stimulating prolactin secretion from perfused isolated and dispersed rat pituitary cells 28
Sexually arousing stimuli, coping mechanisms and hormonal response 27
I neurotrasmettitori ed i neurormoni nel controllo del comportamento sessuale maschile 27
Prolactin and GH response to DA-agonist drugs before and after ECT 27
Sexual dysfunction during neuroleptic treatment 27
Sauvagine and ovine CRF : a frog skin peptide as anticipator of a mammalian brain hormone 27
Effetti a breve e lungo termine della somministrazione di PRL e di farmaci bloccanti DAergici sul comportamento sessuale del ratto maschio 27
Neuroendocrine approach in parkinsonian syndromes 27
Studies on extrapiramidal system: action of L-Dopa and different decarboxylase inhibitors on Prolactin secretion. 27
Studi clinici e sperimentali sul meccanismo di azione neuroendocrino dei fosfolipidi cerebrali: il comportamento della prolattina quale marker di tale azione 26
Prolactin and LH secretion in polycystic ovary syndrome 26
The effect of depot neuroleptics on prolactin and clinical response in patients with chronic schizophrenia 26
Role of dopaminergic agents in the treatment of polycystic ovary syndrome 26
Psychoneuroendocrine aspects of polycystic ovary syndrome (PCOS) 26
Domperidone induced hyperprolactinaemia improves clinical symptoms in Parkinson's disease: possible effect of prolactin at nigro-striatal level 26
Prolactin response as an index of the dopaminergic pharmaco-system function in parkinsonian syndromes 26
Gli effetti del trattamento a lungo termine con bromocriptina in pazienti con PCO sindrome e iperprolattinemia 25
Serotonin and neuroendocrine regulation: effect of antiserotonergic drugs on PRL secretion 25
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study 25
La sindrome dell'ovaio policistico 25
Sauvagine, a frog skin peptide, stimulates ACTH and beta-endorphin release from isolated and dispersed rat pituitary cell in perfusion 25
Sauvagine, a frog skin peptide, has a potent prolactine release inhibiting activity on isolated and dispersed rat pituitary cell column 25
Effetto dei neurolettici depot sulla prolattina e risposta clinica in pazienti con schizofrenia cronica 25
Sauvagine (Sau): new perspectives in hypothalamic control of pituitary function 25
Ruolo del sistema dopaminergico nel controllo della eiaculazione 24
In vitro effect of SH 23390, a DA1 receptor antagonist, on AP-DA2 receptors and PRL release 24
Lack of effect of Ritanserin, a specific 5HT2 antagonist, on basal pituitary hormones secretion in normal subjects 24
Neuroendocrine side effects on antipsychotic therapy 24
Valutazione dei livelli plasmatici di prolattina nelle sindromi extapiramidali. Possibilità di valutazione previsionale della risposta terapeutica 24
Neurolettici e sessualità 24
The effects of brain cortex phospholipids on neuroleptic induced hyperprolactinaemia 24
Effect of ranitidine on hypothalamic pituitary gonadal function in man 24
Vie dopaminergiche e comportamento sessuale nell'anziano 23
Peripuberal stress and polycistic ovary syndrome 23
Prolattina e riproduzione nell'uomo 23
Modificazioni della prolattina ematica in corso di terapia medica elettroconvulsivante 23
Ruolo del sistema dopaminergico nel controllo del comportamento sessuale nelle sindromi iperprolattinemiche 23
Role of brain dopamine in the regulation of male sexual behaviour 23
Contraccezione orale, lipidi e lipoproteine 23
Neuroendocrine rhythms in depression 22
Stress and polycystic ovary syndrome 22
Ginecomastia puberale e prolattina 22
Studio in vitro su la steroidogenesi umana androgena testicolare mediante sistema di tessuto-coltura 21
Totale 3.411
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.932
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020243 0 0 0 0 0 43 43 43 28 37 42 7
2020/2021253 3 8 4 61 15 27 4 60 10 6 52 3
2021/20221.067 11 68 64 30 194 7 6 83 84 111 62 347
2022/20231.081 385 75 19 146 117 173 5 45 74 11 17 14
2023/2024356 34 68 6 13 13 7 2 14 4 57 45 93
2024/2025365 83 62 60 10 102 48 0 0 0 0 0 0
Totale 4.148